
Sign up to save your podcasts
Or
On this episode Sarah talks with physician, public health expert, and Watson Faculty Fellow Adam Levine about a new study examining the effectiveness of convalescent plasma treatment for people with Covid-19. Depending on what Adam and his colleagues find, it could mark the beginning of a new phase in the fight against coronavirus.
Adam’s team is looking for volunteers for this study, in Rhode Island and across the country. You can find out if you qualify and learn how to get involved by following the links below:
Trial for people currently infected with Covid-19.
Trial for people who are at high risk of infection.
Adam Levine is Director of the Center for Human Rights and Humanitarian Studies at the Watson Institute, as well as Director of the Division of Global Emergency Medicine at the Warren Alpert Medical School of Brown University.
You can learn more about Watson’s other podcasts here.
4.9
7676 ratings
On this episode Sarah talks with physician, public health expert, and Watson Faculty Fellow Adam Levine about a new study examining the effectiveness of convalescent plasma treatment for people with Covid-19. Depending on what Adam and his colleagues find, it could mark the beginning of a new phase in the fight against coronavirus.
Adam’s team is looking for volunteers for this study, in Rhode Island and across the country. You can find out if you qualify and learn how to get involved by following the links below:
Trial for people currently infected with Covid-19.
Trial for people who are at high risk of infection.
Adam Levine is Director of the Center for Human Rights and Humanitarian Studies at the Watson Institute, as well as Director of the Division of Global Emergency Medicine at the Warren Alpert Medical School of Brown University.
You can learn more about Watson’s other podcasts here.
1,020 Listeners
4,336 Listeners
104 Listeners
145 Listeners
54 Listeners
779 Listeners
591 Listeners
58 Listeners
2,188 Listeners
1,486 Listeners
86 Listeners
346 Listeners
3,397 Listeners
394 Listeners
291 Listeners